Enrichment of Circulating and Mucosal Cytotoxic CD8+ T Cells Is Associated with Postoperative Endoscopic Recurrence in Patients with Crohn's Disease

J Crohns Colitis. 2016 Mar;10(3):338-45. doi: 10.1093/ecco-jcc/jjv211. Epub 2015 Nov 19.

Abstract

Background and aims: Evidence from mouse colitis models indicates that cytotoxic CD8+ T cells [CTL] play a key role in the initiation of gut lesions. We investigated whether changes in CD8+ CTL in blood or lamina propria [LP] of the neoterminal ileum were associated with postoperative endoscopic recurrence of Crohn's disease [CD].

Methods: A total of 37 CD patients with ileocolonic resection were endoscopically followed up at 6 and 12 months post-surgery. CD8+ T cells were analysed by flow cytometry in blood and ileal LP.

Results: Granzyme B- and perforin-producing CD8+ T cells were significantly increased at 6 months in blood and in ileum LP in patients with endoscopic recurrence, as compared with those in remission. At a cutoff point of 45% of CD8+ CTL, the overall accuracies of the frequency of blood granzyme B+ or perforin+ CD8+ T cells to identify patients with postoperative endoscopic recurrence were 77% and 83%, respectively. Interestingly, patients with endoscopic recurrence at 12 months were those showing the highest mucosal CD8+ CTL frequency at 6 months, while still in remission.

Conclusions: Enrichment of cytotoxic CD8+ T cells in blood and ileal mucosa coincides with CD postoperative endoscopic recurrence. This underscores that CD8 CTL may play a pathophysiological role in the initiation of gut lesions during CD.

Keywords: CD8+ cytotoxic T cells; Crohn’s disease; Postoperative recurrence.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Case-Control Studies
  • Colectomy*
  • Colonoscopy
  • Crohn Disease / diagnostic imaging
  • Crohn Disease / immunology*
  • Crohn Disease / surgery*
  • Female
  • Follow-Up Studies
  • Humans
  • Ileum / immunology*
  • Ileum / surgery
  • Intestinal Mucosa / immunology*
  • Male
  • Middle Aged
  • Prospective Studies
  • Recurrence
  • T-Lymphocytes, Cytotoxic / metabolism*
  • Treatment Outcome